|
Soler-Espejo E, Chen Y, Rivera-Caravaca JM, Sanchez-Salas JA, Esteve-Pastor MA, Marin F, Roldan V, Lip GYH. Relation of the stress hyperglycaemia ratio to residual risk in anticoagulated patients with atrial fibrillation: A report from the prospective Murcia AF Project III cohort. Diabetes Obes Metab. 2025 Dec 4. doi: 10.1111/dom.70335. Online ahead of print. PubMed PMID: 41342100.
AÑO: 2025; IF: 5.7
|
41342100
|
Soler-Espejo E, Ramos-Bratos MP, Gonzalez-Lozano E, Lip GYH, Marin F, Rivera-Caravaca JM, Roldan V. Association between baseline adherence to a healthy lifestyle with ischemic and major cardiovascular events in patients with atrial fibrillation. Eur J Prev Cardiol. 2025 May 14:zwaf287. doi: 10.1093/eurjpc/zwaf287. Online ahead of print. PubMed PMID: 40366897.
AÑO: 2025; IF: 7.5
|
|
Soler-Espejo E, Chen Y, Roldan V, Marin F, Rivera-Caravaca JM, Lip GYH. Prognostic value of adiposity indices in anticoagulated patients with atrial fibrillation: The prospective Murcia AF Project III cohort. Am J Clin Nutr. 2025 Dec 30:101184. doi: 10.1016/j.ajcnut.2025.101184. Online ahead of print. PubMed PMID: 41478434.
AÑO: 2025; IF: 6.9
|
|
Soler-Espejo E., Marín F., López-Gálvez R., Ramos-Bratos M.P., Sánchez-Villalobos M., Esteve-Pastor M.A., Lip G.Y.H., Rivera-Caravaca J.M., Roldán V. The Neutrophil-to-Lymphocyte Ratio Is an Independent Inflammatory Biomarker for Adverse Events in Patients With Atrial Fibrillation: Insights From the Murcia AF Project II (MAFP-II) Cohort Study. Clinical Cardiology. February 2025. 48. 10.1002/clc.70102
AÑO: 2025; IF: 2.3
|
|
Serna MJ, Rivera-Caravaca JM, Lopez-Galvez R, Soler-Espejo E, Lip GYH, Marin F, Roldan V. Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients. Rev Esp Cardiol (Engl Ed). 2024 Oct;77(10):835-842. doi: 10.1016/j.rec.2024.02.011. Epub 2024 Mar 7. English, Spanish. PubMed PMID: 38460882.
AÑO: 2024; IF: 4.9
|